BridgeBio have substantially advanced the progress of a new therapy for amyloid heart disease, utilizing the compound. Initial clinical information indicates promising benefits for those diagnosed by this severe https://bridgebio595633.blogstival.com/63771586/company-improves-cardiac-amyloidosis-treatment-using-the-drug